Our scientists are leading breakthrough discoveries, click the links below to check out our abstracts that will be featured online as part of this year’s ASCO Annual Meeting.
- A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients.
- Inching towards precision medicine for multiple myeloma with causal network models.
- Investigating racial differences in treatment responses through analysis of real-world data (RWD).
- Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).
Stop by Booth #7140 to learn why Sema4 is a leader in technology, research, and patient care.